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Abstract: Several in vitro studies have suggested that silica nanoparticles (NPs) might induce adverse
effects in gut cells. Here, we used the human colon cancer epithelial cell line HCT116 to study the
potential cytotoxic effects of ingested silica NPs in the presence or absence of serum. Furthermore,
we evaluated different physico-chemical parameters important for the assessment of nanoparticle
safety, including primary particle size (12, 70, 200, and 500 nm) and surface modification (–NH2
and –COOH). Silica NPs triggered cytotoxicity, as evidenced by reduced metabolism and enhanced
membrane leakage. Automated microscopy revealed that the silica NPs promoted apoptosis and
necrosis proportional to the administered specific surface area dose. Cytotoxicity of silica NPs was
suppressed by increasing amount of serum and surface modification. Furthermore, inhibition of
caspases partially prevented silica NP-induced cytotoxicity. In order to investigate the role of specific
cell death pathways in more detail, we used isogenic derivatives of HCT116 cells which lack the
pro-apoptotic proteins p53 or BAX. In contrast to the anticancer drug cisplatin, silica NPs induced
cell death independent of the p53–BAX axis. In conclusion, silica NPs initiated cell death in colon
cancer cells dependent on the specific surface area and presence of serum. Further studies in vivo are
warranted to address potential cytotoxic actions in the gut epithelium. The unintended toxicity of
silica NPs as observed here could also be beneficial. As loss of p53 in colon cancer cells contributes to
resistance against anticancer drugs, and thus to reoccurrence of colon cancer, targeted delivery of
silica NPs could be envisioned to also deplete p53 deficient tumor cells.
Keywords: synthetic amorphous silica; nanoparticles; colon cells; in vitro toxicity; cell death
1. Introduction
Synthetic amorphous silica (SAS) nanoparticles (NPs) are produced in large amounts for
applications in industry and medicine. Many consumer products including food contain SAS,
which occurs in different forms depending on the process of its manufacture. Food-grade SAS (E551)
includes fumed (pyrogenic) silica and hydrated silica (precipitated silica, silica gel, and hydrous silica).
Colloidal silica (silica sol) is not authorized as a food additive [1], but is an emerging material for
various biomedical applications such as drug delivery [2]. Addition of SAS to food products has,
for example, stabilizing, anti-caking, anti-settling, and emulsifying effects [3].
SAS food additive has been used for decades and is considered to be safe for consumers.
Yang et al. [4] reported the occurrence of SAS at 1.3–16.3 mg Si/g dry food product, mainly in processed
food such as coffee creamer, pudding powder, cake mix, or in probiotic tablets. In all exposure scenarios
studied by EFSA (European Food Safety Authority), the lowest exposure was reported in the elderly,
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while the highest was in infants and in children, ranging from 3.9 to 74.2 mg/kg body weight per day
and from 8.4 to 162.7 mg/kg body weight per day, respectively [1].
The effects of oral uptake of food-grade SAS nanoparticles have been reviewed recently [1,3,5–8].
In vivo studies with rats found no acute toxicity due to SAS ingestion, but fibrosis in the liver at high
dosages [9]. In a study with mice, upon oral exposure to SAS NPs, increased pro-inflammatory cytokine
levels (IL-1β, IL-6, and TNF-α) were detected in the colons. Additionally, ingested SAS NPs increased
the richness and diversity of microbial species within the intestinal tract [10]. Recently, Siemer et al.
found that nanomaterials including SAS impact the (patho)biology of bacteria occurring in the gut [11].
In addition, in vitro studies suggest that food-grade SAS is potentially hazardous. In particular,
fumed SAS is more toxic than previously assumed. The study of Zhang et al. [12] showed that
fumed silica was more active in producing ROS (Reactive Oxygen Species) and causing red blood cell
hemolysis. In Caco-2 cells, fumed SiO2 NPs induced cytotoxicity, DNA damage, and glutathione (GSH)
depletion in serum-free medium [13,14]. Using human HT29 colon cells, it has been demonstrated
that silica NPs are taken up into cells and stimulate cell proliferation under high-serum conditions.
Under low-serum-conditions, cytotoxic effects were observed [15]. The study also found that SiO2-NPs
enhanced the biosynthesis of GSH via the mitogen activated protein kinase (MAPK) pathway and
caused oxidative DNA damage. Activation of the MAPK pathway and cytotoxicity in response to
silica NPs were also observed in the human stomach cell line GXF252L [16].
Winter et al. found that SiO2-NPs affected the viability of murine dendritic cells and activated the
inflammasome, suggesting that oral administration of these NPs could promote intestinal inflammatory
responses [17]. More recently, the Toll-like receptor signaling pathway was demonstrated to be upstream
of the inflammasome, and is essential in murine dendritic cells for the induction and release of IL-1β in
response to food-grade nanosilica [18].
Before the particles reach the cells of the intestinal mucosa, they must pass the gastrointestinal tract,
encompassing the oral cavity, esophagus, stomach, and intestine, and are exposed to different chemical
conditions. The fluids in the gastrointestinal lumen contain complex mixtures of biomolecules such
as digestive enzymes and food in different stages of digestion. Furthermore, osmotic concentration,
pH, and the gut microbiome change during the passage through the gastrointestinal tract. All these
parameters affect the ingested NPs and can alter the physico-chemical properties of the particles,
which may influence the toxicological outcome [19]. Therefore, it is very difficult or nearly impossible
to mimic all the parameters and physiological conditions encountered in vivo in an in vitro experiment.
Furthermore, it has been demonstrated that biomolecules, in particular, proteins, bind to the particle
surface and form a so-called biomolecular corona [20,21], which has consequences for the biological
activity of nanomaterials [22,23]
The epithelial barrier of the gut represents a target for potentially cytotoxic effects of ingested
silica NPs. As in the absence of a protective protein corona silica NPs induce cell death, for example,
in lung epithelial and phagocytic cells, reminiscent of apoptosis [24,25], we wanted to investigate the
role of specific cell death pathways in intestinal epithelial cells in more detail. Therefore, we used
the human colon epithelial cancer cell line HCT116 as a model to evaluate the cytotoxic effects of
SiO2-NPs as a function of different physico-chemical parameters important for the assessment of
nanoparticle safety [26,27], i.e., concentration (10, 25, 50, and 100 µg/mL), duration of exposure (5, 24,
and 48 h), particle size (12, 70, 200, and 500 nm), surface modification (–NH2 and –COOH), and
protein coating with fetal bovine serum (FBS). Besides the wild-type cells, we used their isogenic
derivatives, which lack the p53 or bax gene [28], to clarify the role of these pro-apoptotic factors for
SiO2-NP-induced cell death.
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2. Materials and Methods
2.1. Materials
Materials and reagents were obtained from the following suppliers: Dulbecco’s modified Eagle’s
medium (DMEM) (cat no 41966), cell culture medium supplements, Hank’s balanced salt solution
(HBSS, cat no 14025), Dulbecco’s phosphate-buffered saline (DPBS, cat no 14190094), BCA (bicinchoninic
acid) protein quantitative assay kit (cat no 23225): ThermoFisher Scientific (Dreieich, Germany); fetal
bovine serum (FBS),Lactate dehydrogenase (LDH)cytotoxicity detection kit (cat no 11644793001),
Hoechst 33258 (Hoechst, cat no B2261), propidium iodide (PI, cat no P4170), CDDP [cisplatin,
cis-diamineplatinum (II) dichloride, cat no P4394], chemicals for sodium dodecylsulfate polyacrylamide
gel electrophoresis (SDS-PAGE), and standard laboratory chemicals: Sigma-Aldrich (Taufkirchen,
Germany); AlamarBlue reagent: AbD Serotec (Puchheim, Germany, cat no BUF012B); Aerosil®
200 (SiO2—12 nm): Evonik Industries (Frankfurt am Main, Germany); Stöber-synthesized silica
SiO2—70 nm cat no 43-00-701, SiO2-NH2—70 nm cat no 43-01-701, SiO2-COOH—70 nm cat no 43-02-701,
SiO2—200 nm cat no 43-00-202, SiO2—500 nm cat no 43-00-502: Micromod Partikeltechnologie (Rostock,
Germany). All particles are listed in Table 1.
Enhanced chemiluminescence (ECL) reagents were obtained from GE Healthcare Amersham
(cat no 2232). Antibodies for detection of cleaved caspase 3 (Asp 175, cat no 9661), caspase 8 (1C12, cat
no 9746), and cleaved caspase 9 (Asp 315, cat no 9505) were purchased from Cell Signaling Technology
(Frankfurt am Main, Germany). Antibodies against p53 (DO-1, cat no sc-126) and PCNA (PC-10,
cat no sc-56) were from Santa Cruz (Heidelberg, Germany). Secondary horseradish-peroxidase
(HRP)-conjugated antibodies: DAKO (Hamburg, Germany), pan-caspase inhibitor Q-VD-
OPh: 5-(2,6-Difluorophenoxy)-3-[[3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-
oxo-pentanoic acid hydrate: MP Biomedicals, Heidelberg, Germany, cat no 03OPH10901.
2.2. Particle Suspensions and Characterization
For treatment of cells, the particle stock suspensions were generated just before preparing the
diluted particle suspensions in cell culture medium with or without serum, which were added to the
cells. Aerosil® 200 NPs delivered as powder were suspended in sterile deionized water at 1 mg/mL,
shortly vortexed and probe sonified with 15 strokes, 15% cycle duty, output control 5 (Branson Sonifier
250, Schwäbisch Gmünd, Germany). The other colloidal silica particles, which were delivered as
suspension, were diluted to 1 mg/mL in deionized water and vortexed. These stock solutions were
further diluted in medium to the desired concentrations.
For analysis by dynamic light scattering (DLS), NPs were further diluted to 50 µg/mL in deionized
water or DMEM with or without serum. The samples were then analyzed directly after vortexing
using the Zetasizer Nano ZS (Malvern Instruments Ldt., Herrenberg, Germany) at 25 ◦C.
For analysis by transmission electron microscopy (TEM), the particle suspensions in water were
transferred onto TEM grids (Plano, SF162-6), dried, and analyzed by a Zeiss electron microscope
(Zeiss 109T, Oberkochen, Germany) [29].
2.3. Calculation of the Effective Density and the Deposited Dose
To compare the effects of differently sized SiO2 particles, it was necessary to calculate the real dose
deposited onto the cells over 24 h, as already described previously [30]. Briefly, the effective density
of the particles in the respective medium was determined by the volumetric centrifugation method
(VCM) according to Deloid et al. [31] at the highest applied concentration of 100 µg/mL. 1 mL of the
particle suspension was filled into a packed cell volume (PCV) tube (TPP Techno Plastic Products,
Trasadingen, Switzerland) and centrifuged in a swinging bucket rotor at 3.000 g for 1 h to collect the
agglomerates in the capillary section of the tube. The volume of the pellet was determined using a
measuring device from TPP Techno Plastic Products (Trasadingen, Swizerland). The effective density
was then calculated according to the formula given in Deloid et al. [32]. The relative in vitro dose (RID)
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was determined by calculating the particle mass deposited onto the cell surface after 24 h using the
distorted grid (DG) nanotransport simulator [33], based on hydrodynamic size (Table S1), effective
density (Table S2), and other parameters in the respective media.
2.4. Cells
HCT116 wt, p53−/−, and BAX−/− cells (kindly provided by B. Vogelstein, John Hopkins University,
Baltimore, MD, USA) were cultured as described before [34]. Briefly, the cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
100 U/mL penicillin and 100 mg/mL streptomycin at 37 ◦C in a humidified atmosphere containing 5%
CO2. Medium was changed every 2 days. Control cells were treated with medium alone or with 0.1%
DMSO, the solvent used for the caspase inhibitor.
2.5. Cell Death Analysis by Fluorescence Microscopy
For detection of cell number and stages of cell death by automated microscopy, 8000 cells were
seeded per well of a 96 well plate. On the next day, the cell culture medium was discarded and the
cells were treated according to the experimental design. After the incubation period, analysis was
performed as previously described [30]. Briefly, Hoechst 33342 and propidium iodide (PI) were added
to a final concentration of 0.3 µg/mL and 0.5 µg/mL, respectively. After 30 min incubation in the
dark, bright field (BF) and fluorescence images were acquired from four positions in the well using an
automated Olympus IX81 fluorescence microscope and a 10× objective (Olympus, Hamburg, Germany).
The Hoechst dye was detected at excitation and emission wavelengths of 350 and 450 nm, respectively.
PI dye was detected at 488 nm and 590 nm, respectively. The images were analyzed by the scanˆR
analysis software (version 2.7.3, Olympus, Hamburg, Germany) to obtain the total number of cells
(Hoechst channel) and the number of early apoptotic, late apoptotic, and necrotic cells (combination of
Hoechst and PI channel), as described previously [30].
2.6. Real-Time Imaging at the Single Cell Level
For real-time imaging at single cell level, HCT116 cells were first seeded in 96 well plates,
as described above, and incubated overnight. Real-time imaging was performed as published
previously [25]. Briefly, before treatment with particles, cells were stained with 0.1 µg/mL Hoechst
and 0.083 µg/mL PI for 1 h at 37 ◦C and 5% CO2, followed by an incubation with SiO2 NPs over 24 h
in a microscope incubator box (EMBLEM, Heidelberg, Germany) under control of CO2, humidity,
and temperature (37 ◦C, 5% CO2). Two images per well and channel (bright-field, Hoechst and PI)
were acquired using the automated fluorescence microscope IX81 (Olympus, Hamburg, Germany)
with a 20-fold objective. The NIH ImageJ Software (version 1.50b, Bethesda, MD, USA) was used to
convert images to videos.
2.7. LDH Cytotoxicity Assay
The LDH assay was performed as described previously [35]. Briefly, after treatment with particles,
control cells were treated with 1% (v/v) of Triton X-100 for 30 min to detect the maximum LDH release
(positive control). The whole plates were then centrifuged at 1500 rpm for 5 min and 50 µL of the
supernatant was transferred into a 96 well plate. 50 µL PBS and 100 µL of the LDH working solution,
prepared according to the manufacturer’s instructions, were added per well and incubated at room
temperature for 10 min. By the addition of 50 µL of 1 N HCl, the reaction was stopped. Absorbance was
measured at 490 nm using a multi-well plate reader and analyzed by the software package SoftMaxPro
(version 3.0, Molecular Devices, Ismaning, Germany). Cytotoxicity data are depicted as percentage
relative to the positive control set to 100%.
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2.8. AlamarBlue Viability Assay
The AlamarBlue® assay was performed as described previously [35], using the same plate with
exposed cells as for the LDH assay. The remaining medium was removed and 100 µL of diluted
AlamarBlue® reagent (1:20 in HBSS) was added. After 60 min in the incubator, the samples were
analyzed using a multi-well plate fluorescent reader (Bio-Tek FL600, software package KC4 version
2.7, MWG-Biotech AG, Ebersberg, Germany) at 560 nm excitation and 620 nm emission wavelengths.
Viability data are depicted as percentage relative to the negative control (untreated cells, 100%).
2.9. Protein Detection by Western Blot
Western blot was performed as described before [36]. The cells, which were seeded into 6 well
plates, were treated with the particles according to the experimental design. After treatment, the cells
were lysed in 2× Laemmli buffer (125 mM Tris–HCl, 4% SDS, 20% glycerol, 8% beta-mercaptoethanol,
pH 6.8), boiled at 95 ◦C for 5 min, and sonicated in an ultrasonic water bath (Bandelin Sonorex, Berlin,
Germany) for 10 min. Lysates were loaded on 12 or 15% gels depending on the molecular size of
the protein to be detected for SDS-PAGE. After electrophoresis, the proteins were transferred onto
Immobilon membranes (Millipore, Darmstadt, Germany). Membrane blocking was performed in
5% (w/v) non-fat dry milk powder in Tris-buffered saline containing 1% (v/v) Tween20 (TBS-T) for
1 h. Appropriate primary antibodies were applied in 5% (w/v) non-fat dry milk in TBS-T overnight
at 4 ◦C. After incubation with appropriate HRP-conjugated secondary antibodies for 1 h, enhanced
chemiluminescence (ECL) detection was performed according to the manufacturers’ instructions.
2.10. Statistical Analyses
Data are expressed as mean ± standard deviation (SD). The significance of difference between
two mean values was assessed by the Student’s t-test or the Mann–Whitney Rank Sum test using the
SigmaPlot software (version 11.0, Systat Software GmbH, Erkrath, Germany). A p-value < 0.05 was
considered to be statistically significant.
3. Results and Discussion
3.1. Characterization of Silica Particles
In this study, we used commercial amorphous silica nanoparticles synthesized by different
methods and of different sizes and surface modifications, as listed in Table 1. SiO2—12 nm, also known
as Aerosil® 200, is a hydrophilic pyrogenic silica NP produced by flame synthesis and was delivered
as a powder. SiO2—70 nm NPs were produced by a wet process known as the Stöber method [37]
and were delivered in an aqueous suspension. Amine- and carboxyl-modified silica NPs of the same
size were used to study the effects of surface modification on the toxicity of colloidal silica NPs.
Furthermore, the effect of size was studied by using 200 and 500 nm Stöber-synthesized silica particles.
The primary particle diameter analyzed by TEM was used to calculate the specific surface area of the
particles in m2/g. The particles were further characterized in medium without and with 10% FBS by
dynamic light scattering (Table S1). In DMEM without FBS, all Stöber-synthesized particles showed a
hydrodynamic diameter very close to their primary diameter, indicating a monodisperse suspension.
The hydrodynamic diameter was slightly increased in the medium with 10% FBS, most likely due to
the formation of a protein corona. SiO2—12 nm NPs were already aggregated to 232 nm in medium
without FBS (presumably due to sintering [22]), and further agglomerated in medium with 10% FBS.
A more detailed characterization of Aerosil® 200 according to OECD test guidelines is provided in
Mülhopt et al. [38]. In these studies, trace amounts of Ni (0.1 µg/g) and Cu (0.2 µg/g) were detected by
inductively coupled plasma-mass spectrometry (ICP-MS), which, however, were below the level of
toxicological relevance.
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Table 1. Characteristics of silica nano- and microparticles.
Particles SurfaceModification
Nominal Primary Particle
Diameter (nm) a
Primary Particle
Diameter (nm) b
Specific Surface
Area (m2/g)
SiO2—12 nm
(Aerosil® 200) plain 12 15 ± 10 d 200 ± 25
a
SiO2—70 nm plain 70 55 ± 7 e 55 c
SiO2-NH2—70 nm –NH2 70 55 ± 7 e 55 c
SiO2-COOH—70 nm –COOH 70 64 ± 7 47 c
SiO2—200 nm plain 200 190 ± 20 16 c
SiO2—500 nm plain 500 433 ± 25 6.9 c
a Data provided by the supplier, b analyzed by transmission electron microscopy (TEM), c calculated from the
primary particle size, and the density 2.0 g/cm3 for SiO2 nanoparticles (NPs). d Already published in Reference [38],
e already published in Reference [25].
3.2. Silica NPs Induced Apoptotic and Necrotic Cell Death Which Was Suppressed by the Presence of Serum
The effects of SiO2—12 nm NPs on cell viability after 24 h were tested using the AlamarBlue
and the LDH release assays (Figure 1a,b). Viable cells reduce the AlamarBlue dye by mitochondrial
dehydrogenases and thus change its color. Reduction of AlamarBlue did not change when cells were
exposed to particles dispersed in medium with 10% FBS. However, it decreased dose-dependently
after treatment in the absence of FBS, even at 10 µg/mL of SiO2—12 nm NPs. The results of the LDH
assay correlate well with the AlamarBlue assay. Release of LDH is an indicator of plasma membrane
damage. For cells treated with 10 µg/mL of SiO2—12 nm NPs in FBS-free medium, there was already a
strong release of LDH, which further increased with higher doses. There was no LDH release detected
when cells were exposed to particles suspended in medium with 10% FBS. The cytotoxic effects of
SiO2—12 nm NPs observed after 48 h were similar to those after exposure for 24 h (Figure S1a,b),
indicating a rapid onset of cell damage. Indeed, silica NPs triggered membrane rupture as early
as 5 h after exposure (Figure S2a). In order to mimic the exposure of colon cells from the luminal
side, we further reduced the amount of serum in the exposure medium. Interestingly, silica NPs
also provoked membrane damage at 24 h in the presence of 1% FBS, albeit reduced compared to the
levels induced in the total absence of serum (Figure S2b). The protective effects of just 1% FBS in the
exposure medium were even more obvious at an earlier time point, i.e., 5 h after treatment (Figure S2a).
In conclusion, silica NPs promoted cytotoxicity in HCT116 cells dependent on time, concentration,
and the presence of serum, as previously reported for other cell types [15,16,20,22,23,39].
Next, we used automated fluorescence microscopy to further identify the mechanisms of cell
death. After 24 h in the absence of FBS, the total cell number decreased significantly at increasing
levels of SiO2—12 nm NPs, while, concomitantly, the proportion of dead cells increased (Figure 2c,d).
Similar effects were found at 48 h of exposure (Figure S3). Dead cells showed typical features of cell
death, such as DNA condensation and loss of membrane integrity, and were mainly categorized as late
apoptotic and necrotic cells (Figure 2a,b,d, Video S1). As also documented above using the AlamarBlue
and LDH assays (Figure 1), 10% serum in the exposure medium largely prevented cytotoxicity.
In accordance with the rapid damage of the cell membrane detected by the LDH assay at 5 h in the
absence of serum (Figure S2a), an early influx of propidium iodide indicative of membrane rupture
was also observed at the single cell level (Figure S4a,b). Furthermore, in accordance with the LDH
assay (Figure S2b), the presence of 1% FBS reduced cell death prompted by silica NPs (Figure S5a,b).
These findings, together with previous results obtained with human colon carcinoma [15] and lung
epithelial cells [24], indicate that the ratio of the specific particle surface area and concentration of
proteins in the exposure medium has a critical impact on the occurrence of cell death upon treatment
with silica NPs.
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 Figure 1. Cell viability decreased after incubation with silica NPs in the absence of fetal bovine
serum (FBS). HCT116 wt cells were incubated with SiO2—12 nm NPs at the indicated concentration
in the presence or absence of 10% FBS. After 24 h, cell viability was detected by the AlamarBlue
assay (a). The values were normalized to the negative control (no particles were added, 100%). Lactate
dehydrogenase (LDH) release is shown in (b). The values were normalized to the positive control
(1% Triton X-100, 100%). The data represent the means of seven independent experiments ± SD
performed with six replicates. *** p < 0.001 indicates significant differences in the response of cells
treated with the same amount of NPs in the absence (0% FBS) or the presence of serum (10% FBS).
3.3. Silica NPs Triggered Cell Death Dependent on Size, Specific Surface Area, and Surface Modification
To address the impact of size on silica NP induced cell death under serum-free conditions,
we studied colloidal silica spheres with nominal diameters of 70, 200, and 500 nm (Table 1).
Administration of particles with increasing diameter but at the same mass concentration (10 and
50 µg/mL) revealed an inverse relationship of particle size and cytotoxicity, i.e., larger particles were
less toxic compared to smaller particles (Figure 3a). Similarly to the effects observed for SiO2—12 nm
NPs derived from flame synthesis (Figure 2), colloidal silica NPs also provoked apoptotic and necrotic
cell death dependent on dose and size (Figure 3b, Figure S6). Silica NPs are surface active materials and
interact with biological surfaces, i.e., cell membranes. The specific particle surface area (SSA, cm2 at a
defined mass or volume) increases linearly with a reciprocal decrease in particle size. The dose–response
related to the nominal concentration in the exposure media indicated increased toxicity of smaller
versus larger silica NPs (Figure 3a,b). However, normalization of the dose response curves to the
administered SSA showed a clear correlation of SSA and cytotoxicity (Figure 3c). As the deposited, i.e.,
effective, dose of particles is controlled by sedimentation and diffusion, which depend on particle size
and effective density, we also calculated the delivered cellular dose [33,40]. While for the larger particles
of 200 and 500 nm there was no major difference in the effective SSA dose, for the smaller nanoparticles
(12 and 70 nm), the effective SSA (Figure 3e,f) was drastically reduced compared to the nominal dose
(Figure 3c,d). As deposition of nanoparticles is mainly driven by diffusion, the relative fraction of
administered NPs interacting with cells was lower compared to the larger particles, highlighting the
importance of computational modeling of the relative in vitro dose for hazard ranking of differently
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sized materials. Indeed, several in vitro and in vivo studies have shown that cytotoxicity of insoluble
NPs better correlates with the SSA dose than with the particle mass dose [24,41–43].Nanomaterials 2019, 9, x FOR PEER REVIEW 8 of 18 
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Figure 3. Silica Ps induce cell death dependent on size and specific surface area. T116 t cells
ere incubated ith particles as indicated in the absence of FBS. fter 24 h, the cells ere processed
and analyzed as described in Figure 2. (a) The total cell number divided into living and dead cells.
(b) The percentage of dead cells relative to the total cell number divided into the different classes of cell
death as indicated. Data show ean values of two independent experi ents carried out with four
replicates (n = 8). The error bars are SD values related to the total cell number (a) or the percentage of
total dead cells (b), respectively. * p < 0.05, *** p < 0.001 indicate significant differences in the response
of cells treated with particles in comparison to untreated control cells (-). The percentage of viable
(c) and dead cells (d) are plotted against the nominal specific particle surface area dose per cell area
(cm2/cm2, logarithmic scale). For comparison (e,f), the calculated deposited dose has been used as a
metric. Note that the nominal (c,d) and calculated (e,f) dose in case of larger particles (200 and 500 nm)
were rather similar, whereas for nanoparticles (12 and 70 nm), only a small fraction was deposited.
Further details are described under Methods.
Chemical surface functionalization of silica NPs modulates the cellular response [44,45]. Therefore,
we also investigated in HCT116 cells the effects of colloidal silica NPs of the same size (70 nm)
with a plain, NH2—, or COOH—modified surface. As observed in other cell models, chemical
modification of the silica surface suppressed cytotoxicity (Figure 4a,b; Figure S7). Replacement of
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Figure 4. Surface modifications reduces cytotoxicity of silica NPs. HCT116 wt cells were exposed to
SiO2—NPs (70 nm) with a plain, NH2—, or COOH—modified surface in the absence of FBS. After 24 h,
the cells were processed and analyzed as described in Figure 2. (a) The total cell number divided into
living and dead cells. (b) The percentage of dead cells relative to the total cell number divided into the
different classes of cell death as indicated. Data show mean values of two independent experiments
carried out with four replicates (n = 8). The error bars are SD values related to the total cell number (a)
or the percentage of total dead cells (b), respectively. *** p < 0.001 indicates significant differences in the
number of viable cells (a) and total dead cells (b) after administration of modified NPs compared to
corresponding concentrations of plain particles.
3.4. Silica NPs Promoted Cell Death Dependent on Caspases and Independent of p53 or BAX
Silica NPs induced cell death in HCT116 cells via apoptosis and necrosis, as evidenced by the
image analysis outlined above. Execution of cell death is controlled by intricate signaling networks
and is of relevance for the toxicity of several nanomaterials [48]. The most prominent determinants of
cell death are the tumor suppressor protein p53 and its target BAX [49]. p53 is a transcription factor
which is activated due to cellular stress, and regulates cell growth, cell cycle progression, and cell
death via apoptosis, necroptosis, or ferroptosis. BAX acts on mitochondria to promote apoptosis and
is regulated by p53, which upregulates transcription of the gene encoding BAX. In order to further
investigate the mechanism of cell death triggered by silica NPs, we explored wild-type HCT116 cells
and their isogenic derivatives in which the p53 gene was deleted by homologous recombination [28].
Compared to wild-type cells, silica-NP-induced cell death monitored by automated microscopy at
24 h was not reduced in p53 knock-out cells (Figure 5a,b). The similar sensitivity of p53 deficient
cells was also confirmed by the LDH and AlamarBlue assays (compare Figure S8a,b and Figure 1).
Additionally, at an earlier time point (5 h), no reduced cell death but rather, enhanced cytotoxicity
could be observed in p53 knock-out cells (Figure S9a,b; Figure S10; Figure S2a). Similarly, at 48 h
after exposure to nanosilica, no major difference in the percentage of cell death was obvious when
wildtype and p53 knock-out cells were compared (Figure S11). Next, we analyzed the involvement of
the p53 target BAX in the execution of nanosilica-induced cell death. Again, as found in the case of p53
deficient cells, BAX knock-out cells were not protected against the detrimental action of nanosilica
(Figure 5a,b). In summary and in contrast to the action of some genotoxins [28,34], the p53–BAX axis
seems not to be involved in the execution of cell death prompted by exposure to nanosilica in HCT116
cells. Previous reports have suggested a pro-apoptotic role of p53 and BAX in nanosilica-induced
cell death [50,51]. After treatment with silica NPs, an upregulation of the p53 and BAX proteins in
human fetal hepatocytes and hepatoma cells could be demonstrated, which correlates with the onset
of cell death. However, further studies in these and other cell types are warranted to really confirm a
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functional role of p53 and BAX (e.g., by genetic or pharmacological interference) in nanosilica-induced
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Figure 5. Silica NPs induce cell death independent of p53 and BAX. HCT116 wild-type (wt), p53
knock-out (−/−) and BAX knock-out (−/−) cells were incubated with SiO2—12 nm NPs as indicated in the
absence of FBS. After 24 h, the cells were processed and analyzed as described in Figure 2. (a) The total
cell number divided into living and dead cells. (b) The percentage of dead cells relative to the total cell
number divided into the different classes of cell death as indicated. Data show mean values of five–six
independent experiments with wt and p53−/− cells. For BAX−/− cells, one representative experiment
out of two is shown. All experiments were carried out with three–four replicates. The error bars are SD
values related to the total cell number (a) or the percentage of total dead cells (b), respectively. Note
that there was no major difference in the response of p53−/− or BAX−/− compared to wild-type cells.
* p < 0.05.
Finally, we addressed the involvement of caspases in silica-NP-induced cell death. Indeed,
inhibition of caspases partially protected cells from silica-NP-induced cell death, evidenced by an
increase of viable cells (Figure 6a) and a decrease in apoptotic and necrotic cells (Figure 6b). As also
shown for the positive controls, which were treated with the genotoxin cisplatin, caspases are required
for the promotion of cell death initiated by silica NPs. Next, we monitored cleavage of caspase 8
and caspase 9, which act as initiator caspases in the extrinsic (as part of the death-inducing signaling
complex) and intrinsic (as part of the apoptosome) apoptotic pathways, respectively [52]. Exposure of
cells to increased amounts of silica NPs triggered cleavage of caspase 8 and 9 (Figure 6c), in line with a
critical role of caspase activity in the execution of cell death (Figure 6a,b). Furthermore, in contrast to
the positive control cisplatin, silica NPs did not elevate the protein levels of p53 (Figure 6c). This also
supports the loss of function experiments, i.e., similar cytotoxicity in wt and p53 knock-out cells after
exposure to silica NPs (Figure 5a,b).
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presence of low amount of serum, corroborating previous studies in the two different human colon 
cancer cell lines Caco-2 and HT29 [13,14]. In Caco-2 cells, a pro-inflammatory action of silica NPs was 
also observed indicated by the release of IL-8 [53]. Interestingly, differentiated Caco-2 cells were less 
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Figure 6. Silica NPs induce cell death dependent on caspases. HCT116 wt cells were incubated with
10 µg/mL SiO2—12 nm NPs or with 50 µM of the positive control compound cisplatin (CDDP) in
medium without FBS. Samples were co-treated as indicated either with the pan-caspase inhibitor
Q-VD-OPh (10 µM) dissolved in DMSO (0.5%) or simply the solvent (DMSO, 0.5%). After 24 h, the cells
were processed and analyzed as described in Figure 2. (a) The total cell number divided into living and
dead cells; (b) the percentage of dead cells relative to the total cell number divided into the different
classes of cell death as indicated. Data show mean values of two independent experiments carried
out with four replicates (n = 8). The error bars are SD values related to the total cell number (a) or
the percentage of total dead cells (b), respectively. *** p < 0.001 indicates significant differences in
the response of cells treated with or without the pan-caspase inhibitor. (c) Activation, i.e., cleavage
of caspase 8 and 9 was analyzed by western blotting after treatment with 0 (co.), 5 and 10 µg/mL
SiO2—12 nm NPs or with 50 µM CDDP in the absence of serum for 22 h. PCNA was used as a loading
control. The results are representative of two independent experiments.
4. Conclusions and Perspectives
Engineered silica nanoparticles are ingested as food additives and belong, together with titania
NPs, to the most frequently used nanomaterials in food products [8]. The present study revealed
cytotoxic actions of silica NPs in the colon cancer cell line HCT116, specifically in the absence or
presence of low amount of serum, corroborating previous studies in the two different human colon
cancer cell lines Caco-2 and HT29 [13,14]. In Caco-2 cells, a pro-inflammatory action of silica NPs
was also observed indicated by the release of IL-8 [53]. Interestingly, differentiated Caco-2 cells were
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less sensitive to the noxious effects of silica NPs. The physiological relevance of in vitro studies
needs to be considered, and specific test systems and guidelines still need to be optimized in case
of hazard and risk assessment of NPs upon ingestion [8]. With respect to dosimetry, we chose a
realistic dose range for all different silica nanoparticles below the calculated relevant in vitro dose
of about 2 µg/cm2 (NP mass/cellular surface area), approximated from the daily average intake of
food grade silica (1.8 mg/body weight/day) in humans [8]. Unfortunately, there is a lack of in vivo
studies investigating toxicity of silica NPs in the gut. Recently, production of pro-inflammatory
cytokines upon oral administration of nanosilica (2.5 mg/kg bw/day) for 7 days was observed in
mice, which coincided with slight histological changes, i.e., crypt damage and inflammatory cell
infiltration [10]. Thus, it is tempting to speculate that microlesions in the gut epithelium due to cell
death could contribute to the inflammatory symptoms. In the colonic crypts, there is a constant renewal
of epithelial cells, which originate from stem cells and progressively differentiate to become mature
enterocytes. Clearly, more detailed studies in vivo are warranted to address the impact of nanosilica
on the viability of epithelial cells, and also in relation to their differentiation status. It is of note that
the in vitro experiments of Wiemann et al. with alveolar macrophages cultivated under serum-free
conditions have been demonstrated to predict the short-term inhalation toxicity in vivo for 18 different
nanomaterials, including nanosilica [54]. Upon inhalation, NPs are covered by the lung lining fluid,
mostly comprised of surfactant (primarily phospholipids) and a small amount of proteins, and are
not covered by serum proteins. Therefore, in vitro exposure of lung cells in the presence of high
levels of serum proteins (i.e., 10% FBS) does not closely mimic the physiological conditions in the
lung. Concerning a realistic exposure scenario for the gastrointestinal tract, NPs are embedded in a
complex food matrix, which is further altered upon ingestion and digestion. Therefore, the corona,
i.e., the adsorbed molecules on the NP surface, is ill-defined and comprised of a multitude of different
molecules including carbohydrates, protein, and lipids. However, compared to localization of NPs in
the blood stream after direct injection (in the case of medical applications) or after translocation from
the gut into the portal vein, the amount of serum proteins in the gut lumen is much lower. Hence,
the presence of high levels of serum proteins as used in most in vitro experiments might passivate
the silica surface and suppress the interaction of silica NPs with critical targets such as the cellular
membrane or certain receptors. Although in vitro experiments employing monocultures can be used
to address specific processes and pathways, co-cultures of colon epithelial cells together with mucus
producing goblet cells or lymphoid cells might even be better suited to predicting the more complex
situation in vivo. Indeed, exposure of differentiated Caco-2 cells co-cultured with mucus producing
HT29-MTX cells to titania NPs triggered the production of reactive oxygen species [55–57] and an
inflammatory response, which was absent in Caco-2 cells grown as monocultures.
Finally, in vitro studies in toxicology often rely on the use of transformed cancer cells, as primary
cells of various organs are difficult to cultivate and are often not available. Therefore, adverse effects
observed in vitro might indicate toxicity in vivo, but need to be confirmed in follow-up investigations.
However, the unintended toxicity of NPs determined in vitro might also be beneficial and exploited
to selectively eliminate cancer cells. Specifically, silica NPs also kill p53-deficient colon cancer cells,
as shown here, which are resistant to chemotherapy by conventional drugs such as cisplatin. Hence,
oral delivery of silica NPs could be envisioned for the treatment of colon cancer. Selective accumulation
of silica NPs via tumor-targeting ligands could be combined with the tunable unmasking of the silica
surface, e.g., by dePEGylation initiated by near infrared radiation, as shown recently [58].
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/9/8/1172/s1,
Table S1: Characterization of SiO2 particle suspensions. Table S2: Nominal and effective i.e., calculated dose
of differently sized SiO2 particles. Figure S1: Cell viability decreases after incubation with SiO2—12 nm NPs
for 48 h in the absence of FBS. Figure S2: Low amount of serum (1% FBS) delays and reduces but does not
totally prevent membrane damage provoked by SiO2—12 nm NPs. Figure S3: Cell death upon treatment with
SiO2—12 nm NPs for 48 h in the absence of FBS. Figure S4: SiO2—12 nm NPs disturb the integrity of the cell
membrane in the absence of FBS as indicated by the influx of propidium iodide already after 5 h. Figure S5: The
toxic effects of SiO2—12 nm NPs after 24 h are diminished in the presence of 1% FBS. Figure S6: Silica NPs induce
apoptotic and necrotic cell death dependent on size. Figure S7: Cytotoxicity of silica NPs is suppressed by surface
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modification. Figure S8: Cell viability decreases after incubation of HCT p53−/− cells with SiO2—12 nm NPs for
24 h in the absence of FBS. Figure S9: HCT116 p53−/− cells are more sensitive to SiO2—12 nm NPs than HCT116
wt cells. Figure S10: Low amount of serum (1% FBS) reduces membrane damage provoked by SiO2—12 nm NPs.
Figure S11: The response of HCT116 wt and p53−/− cells to SiO2—12 nm NP exposure after 48 h is similar. Figure
S12: Summary of the results from the different toxicity assays to demonstrate the similar sensitivity of HCT wt
and p53−/− cells to SiO2—12 nm NPs dependent on the concentration of FBS. Video S1: Time course of cell death
after incubation to SiO2—12 nm NPs in the absence of serum.
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